Dec 16, 20211 minTUBB4A-associated leukodystrophyDr Dan Williams, CEO and Co-Founder of new biotech business SynaptixBio, discusses how the search is on to find the first treatment for...
Dec 16, 20211 minBusiness digest C&I Issue 11, 2021SynaptixBio, an Oxford, UK-based research company, has been launched by a worldwide team of medical and pharmaceutical scientists to...
Dec 16, 20211 minNew biotech firm launched to develop ‘revolutionary’ treatment for one of world’s rarest diseasesA new biotech business SynaptixBio has been launched to tackle one of the world’s rarest neurodegenerative diseases. SynaptixBio is...
Dec 16, 20211 minOxford Biotech Firm Launches To Tackle Rare Disease – Insider LimitedA biotech business has launched in Oxford in a bid to tackle one of the world’s rarest diseases. SynaptixBio is working to develop a...
Dec 16, 20211 minOxford biotech firm launches to tackle rare diseaseA biotech business has launched in Oxford in a bid to tackle one of the world's rarest diseases. SynaptixBio is working to develop a...
Aug 18, 20211 minSynaptixBio launched with singular focusA new biotech company has been launched with the goal of taking on one of the world’s rarest neurodegenerative… To continue reading...
Aug 18, 20211 minDanish biotech profile is helping to establish its fourth company abroadBent Jakobsen, who has previously co-founded three biotech companies abroad, is now helping to establish his fourth of its kind,...
Aug 18, 20211 minSynaptixbio sets off on quest to find therapy for rare CNS diseaseU.K.’s Synaptixbio Ltd. has launched, aiming to tackle a rare and often fatal disease of the central nervous system (CNS), TUBB4a...
Aug 18, 20211 minOxford biotech firm SynaptixBio launched to develop ‘revolutionary’ treatment A new biotech business has been launched in Oxford to tackle one of the world’s rarest diseases. SynaptixBio is working to develop the...
Aug 18, 20211 minBiotech to develop treatment for neurodegenerative diseaseA team of medical and pharmaceutical experts has founded SynaptixBio, an Oxford-based research company working to develop the world’s...
Aug 18, 20211 minThis week in drug discovery (18-22 October) News round-up by DDW’s Megan Thomas for 18-22 October DDW’s Megan Thomas has selected five stories which highlight the opportunities in...
Aug 18, 20211 minSynaptixBio Formed to Tackle One of the World’s Rarest DiseasesSynaptixBio CEO and Co-Founder Dan Williams/Courtesy SynaptixBio TUBB4a-related leukodystrophy is considered one of the rarest diseases...